Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4251 USD | +0.02% | +9.00% | -3.36% |
Financials (USD)
Sales 2024 * | 113K | Sales 2025 * | 1.78M | Capitalization | 21.21M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -25M | EV / Sales 2024 * | 187 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 11.9 x |
P/E ratio 2024 * |
-0.87
x | P/E ratio 2025 * |
-0.93
x | Employees | 27 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.18% |
Latest transcript on AIM ImmunoTech Inc.
1 day | +0.02% | ||
1 week | +9.00% | ||
Current month | +4.06% | ||
1 month | -13.03% | ||
3 months | +11.87% | ||
6 months | -9.17% | ||
Current year | -3.36% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 22-04-03 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 23-03-27 |
William Mitchell
CHM | Chairman | 89 | 98-06-30 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.4251 | +0.02% | 137,986 |
24-05-07 | 0.425 | +1.19% | 463,502 |
24-05-06 | 0.42 | +3.75% | 173,772 |
24-05-03 | 0.4048 | +0.15% | 48,518 |
24-05-02 | 0.4042 | +3.64% | 117,560 |
Delayed Quote Nyse, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.36% | 21.21M | |
+2.93% | 108B | |
+7.02% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- AIM Stock